Interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination can double their antibody response to the jab, new research finds.
NIHR has launched a new publishing platform that allows researchers to rapidly publish any research information they wish to share, supporting transparency, reproducibility and impact from publicly funded research.
Charities and government research organisations including the NIHR have awarded £4.25 million to MND experts at six UK universities to kick start collaborative efforts to end motor neurone disease (MND)
A single MRI scan of the brain could be enough to diagnose Alzheimer’s disease, according to new research supported by NIHR.
NHS trusts delivering non-commercial clinical research will benefit from additional funding to deliver studies across England - following a financial policy change lowering the point at which trusts can claim back research excess treatment costs.
In a comment piece published in The Lancet Oncology journal, NIHR cancer experts welcomed the Government’s 10 year cancer plan consultation.
A standard two-dose Pfizer-BioNTech or Oxford-AstraZeneca vaccine schedule showed a greater antibody increase when given at a 12-week interval, compared to a four-week interval.
NIHR leaders recognised in Queen’s Jubilee Honours List
NIHR-funded researchers have launched a new study seeking to understand how the COVID-19 pandemic has affected health visiting services across the UK, with a view to improving them in the future.
NIHR is launching an urgent funding call for research into monkeypox
NIHR salutes TrialBlazers in new campaign to take part in health and care research
An NIHR-funded study led by researchers at the NIHR Leicester Biomedical Research Centre has shown that a less invasive heart procedure for a common condition is just as effective as conventional open-heart surgery. The findings are published in the Journal of the American Medical Association (JAMA).
E-cigarettes are just as safe as nicotine patches for pregnant women and may help more women stop smoking, finds new NIHR-funded research.
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from the NIHR-supported COV-BOOST study.
New research funded by NIHR has found that many parents attending commercial weight management programmes would be happy for their child, if overweight, to also receive support to reach a healthier weight.
Dr Peter McGuigan and Dr Alicia Waite have been awarded Established Clinician and Early Career Clinician by the NIHR CRN and the FICM.
The NIHR is delighted to announce that over 1,000 health and care professionals have now got involved with research for the first time as part of the Associate Principal Investigator (PI) Scheme.
NIHR has co-funded a new £6.4m trial which could pave the way for a test to be established as a routine screening programme to detect Barrett’s oesophagus – a condition that can lead to oesophageal cancer.
The latest results from the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses of several COVID-19 vaccines.
The NIHR is proud to publish our Race Equality Framework - a self-assessment tool to help organisations improve racial equality in public involvement in health and care research.
Following rigorous clinical trials supported by the NIHR and thorough data analysis, the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the Valneva COVID-19 vaccine for UK use.
The NIHR-supported PANORAMIC trial is investigating a new COVID-19 antiviral treatment, Paxlovid, among vulnerable groups in the community.
NIHR has co-funded 14 new research projects to develop technologies such as self-care apps, smart devices and wearables to help people transform their care and health at home.
A commonly used means of delivering additional oxygen to children in intensive care is not as effective as many clinicians assume, according to new NIHR-funded research.
Since its establishment in 2006, the NIHR has invested over £200m in more than 470 social care research projects across its portfolio, with £90m worth of NIHR-funded social care studies starting in the last three years.
